切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - S-adenosylhomocysteine hydrolase - Adenosine A2A Receptors - Bromodomain and Extra-Terminal motif (BET) - Vitamin D receptors (VDRs)

12件产品中的 1-10

页面
每页
清除全部
  1. 3-Deazaadenosine
    B6121 3-Deazaadenosine
    中文名: 3-脱氮腺苷
    Target: S-adenosylhomocysteine hydrolase
    Summary: S-腺苷高半胱氨酸(SAH)水解酶抑制剂
      ≥26.6 mg/mL
      ≥7.53 mg/mL
  2. Regadenoson
    B5904 Regadenoson
     1 Citation
    中文名: 类伽腺苷
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体激动剂
      ≥18.05 mg/mL
      insoluble in H2O
  3. SCH 58261
    B6995 SCH 58261
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体竞争性拮抗剂
      ≥34.5 mg/mL
      insoluble in H2O
  4. Calcifediol
    B2140 Calcifediol
    中文名: 骨化二醇
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D3的主要循环形式
      ≥13.65 mg/mL
      insoluble in H2O
  5. Doxercalciferol
    B2091 Doxercalciferol
     1 Citation
    中文名: 度骨化醇
    Target: Vitamin D receptors (VDRs)
    Summary: 维生素D受体激活剂
      ≥11.5 mg/mL
      insoluble in H2O
  6. I-BET151 (GSK1210151A)
    B1500 I-BET151 (GSK1210151A)
     2 Citation
    Target: Bromodomain and Extra-Terminal motif (BET)
    Summary: BET的选择性抑制剂
      ≥41.5 mg/mL
      insoluble in H2O
  7. Lithocholic Acid
    A8463 Lithocholic Acid
    中文名: 石胆酸
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: 维生素D受体PXR和FXR的激活剂
      ≥12.95 mg/mL
      insoluble in H2O
  8. Istradefylline (KW-6002)
    A8454 Istradefylline (KW-6002)
    中文名: 伊曲茶碱
    Target: Adenosine A2A Receptors
    Summary: 选择性A2A受体拮抗剂
      ≥8.78 mg/mL
      insoluble in H2O
  9. Tozadenant
    A3885 Tozadenant
    Target: Adenosine A2A Receptors
    Summary: 腺苷2A受体拮抗剂
      ≥20.35 mg/mL
      insoluble in H2O
  10. Preladenant
    A3735 Preladenant
    Target: Adenosine A2A Receptors
    Summary: 腺苷A2A受体拮抗剂
      ≥7.3 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页